2026 NPPES data Child & Adolescent Psychiatry Physician NPI 1396798120 M.D.
Verify on CMS →

WATUTANTRIGE DEALWIS, M.D.

Child & Adolescent Psychiatry Physician in RIDGEWOOD, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
597
Medicare Part D claims · 25 beneficiaries · Child & Adolescent Psychiatry Physician avg: 600
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.6738/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$626.44
11 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

WATUTANTRIGE DEALWIS, M.D. reported a CMS MIPS final score of 98.6738/100 — above the 83.1 national average — and filed 597 Medicare Part D claims in 2023.

98.6738/100
MIPS score · +16 vs avg
597
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

WATUTANTRIGE DEALWIS, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

WATUTANTRIGE DEALWIS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about WATUTANTRIGE DEALWIS, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 05/19/2006

NPI 1396798120

Primary specialty

Child & Adolescent Psychiatry Physician

Mid-sized

6,160 US NPIs in this specialty

Medicare Part D claims

597 0% vs specialty avg

2023 prescription claims

Specialty avg: 600

MIPS final score

98.6738/100 15.573800000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Child & Adolescent Psychiatry Physician compares to other specialties among New Jersey providers

New Jersey providers

Child & Adolescent Psychiatry Physician share within New Jersey

1. Child & Adolescent Psychiatry Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Child & Adolescent Psychiatry Physician share within New Jersey

Medicare quality performance — MIPS

WATUTANTRIGE DEALWIS, M.D.'s 2023 MIPS final score plotted against the Child & Adolescent Psychiatry Physician national average

High performer (top quartile)
MIPS Final Score
98.6738/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Child & Adolescent Psychiatry Physician) — 98.6738/100 vs national avg 83.1

0%100%National avg83%98.7%
MIPS final score (Child & Adolescent Psychiatry Physician) — 98.6738/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

WATUTANTRIGE DEALWIS, M.D. is a Child & Adolescent Psychiatry Physician provider practicing in RIDGEWOOD, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1396798120. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

WATUTANTRIGE DEALWIS, M.D. appears in the CMS NPPES registry as a Child & Adolescent Psychiatry Physician provider holding M.D. credentials at 223 N VAN DIEN AVE, RIDGEWOOD, NJ, 07450, with a listed phone of (201) 447-8586. NPI 1396798120 was issued on 05/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEALWIS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 597 prescription claims written by this provider, covering 25 Medicare beneficiaries and totaling roughly $81K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.6738/100 for the 2023 performance year (Quality 93.5705), compared with the national average of 83.1.

Child & Adolescent Psychiatry Physician is a mid-sized specialty nationwide, with 6,160 enrolled providers across 54 states and an average of 600 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

223 N VAN DIEN AVE
RIDGEWOOD, NJ 07450

Provider Details

NPI 1396798120
Specialty Child & Adolescent Psychiatry Physician
Credentials M.D.
Gender Male
NPI Issued 05/19/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.6738
Final Score
Avg: 83.1
93.5705
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where WATUTANTRIGE DEALWIS, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

VALLEY PHYSICIAN SERVICES PC
HOBOKEN, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for WATUTANTRIGE DEALWIS, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$626

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

WATUTANTRIGE DEALWIS, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 597 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

597
Total Claims
$81K
Total Drug Cost
25
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
706
Total Day Supply
20,663
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$69K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
59.0 years
Avg HCC Risk Score
1.01

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Risperidone
71
Trazodone Hcl
69
Quetiapine Fumarate
51
Aripiprazole
42
Vraylar
Cariprazine Hcl
40
Clonazepam
37
Sertraline Hcl
34
Bupropion Hcl
26
Escitalopram Oxalate
26
Duloxetine Hcl
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Child & Adolescent Psychiatry Physician Overview

How WATUTANTRIGE DEALWIS, M.D. fits within the Child & Adolescent Psychiatry Physician landscape nationally.

6,160
Child & Adolescent Psychiatry Physician Providers in US
54
States with Child & Adolescent Psychiatry Physician
600
Avg Claims per Provider

WATUTANTRIGE DEALWIS, M.D.'s 597 claims are below the specialty average of 600.

Nearby Child & Adolescent Psychiatry Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as DEALWIS.

Compare Child & Adolescent Psychiatry Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is WATUTANTRIGE DEALWIS, M.D.'s specialty?
WATUTANTRIGE DEALWIS, M.D. specializes in Child & Adolescent Psychiatry Physician and practices in RIDGEWOOD, New Jersey. Credentials: M.D..
How much does WATUTANTRIGE DEALWIS, M.D. prescribe under Medicare Part D?
In 2023, WATUTANTRIGE DEALWIS, M.D. wrote 597 Medicare Part D claims totaling $81K in drug costs for 25 beneficiaries.
What is WATUTANTRIGE DEALWIS, M.D.'s Medicare quality score?
WATUTANTRIGE DEALWIS, M.D. has a CMS MIPS Final Score of 98.6738/100 (Quality: 93.5705). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is WATUTANTRIGE DEALWIS, M.D. located?
WATUTANTRIGE DEALWIS, M.D. is located at 223 N VAN DIEN AVE, RIDGEWOOD, NJ, 07450. Phone: (201) 447-8586.
What is WATUTANTRIGE DEALWIS, M.D.'s NPI number?
WATUTANTRIGE DEALWIS, M.D.'s National Provider Identifier (NPI) is 1396798120, issued on 05/19/2006.
Does WATUTANTRIGE DEALWIS, M.D. prescribe more brand-name or generic drugs?
WATUTANTRIGE DEALWIS, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $69K in brand drug costs.
How many Child & Adolescent Psychiatry Physician providers are there in the US?
There are 6,160 Child & Adolescent Psychiatry Physician providers across 54 states in the US. The average Child & Adolescent Psychiatry Physician provider writes 600 Medicare Part D claims per year.
What drugs does WATUTANTRIGE DEALWIS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, WATUTANTRIGE DEALWIS, M.D.'s most frequently prescribed drugs include Risperidone, Trazodone Hcl, Quetiapine Fumarate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does WATUTANTRIGE DEALWIS, M.D. accept Medicare?
WATUTANTRIGE DEALWIS, M.D. appears in CMS Medicare data with 597 Part D claims and 25 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify WATUTANTRIGE DEALWIS, M.D.'s credentials?
WATUTANTRIGE DEALWIS, M.D.'s NPI is 1396798120 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology